Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Neil McGill a C S Mott Children's Hospital,
Section of Pediatric Anesthesiology, Room F3900, Box 0211, Ann Arbor,
MI 48109-0211, USA, b Department of Haematology, Southampton University
Hospitals NHS Trust, Southampton SO16 6YD, c Medical
Statistics Group, Southampton University Hospitals NHS Trust, d Shackleton Department of Anaesthesia, Southampton University
Hospitals NHS Trust
Correspondence to: R Gill ravi.gill{at}suht.swest.nhs.uk
Objective:
To assess the effectiveness of
two mechanical methods of blood conservation in reducing the need for
allogeneic red blood cells or coagulation products during cardiac surgery.
What is already known on this topic
Recent meta-analyses have shown that the mechanical blood conservation
techniques of intraoperative cell salvage and acute perioperative
normovolaemic haemodilution may reduce the need for transfusion, but
flawed methods in trials mean that clear evidence in cardiac surgery is
lacking What this study adds
Combining acute perioperative normovolaemic haemodilution with
intraoperative cell salvage does not confer any additional
benefit
Design:
Randomised controlled trial.
Setting:
Regional cardiac centre in a teaching
hospital in Southampton.
Participants:
263 adults aged 18-80 years
undergoing elective coronary artery bypass surgery entered the study,
of whom 252 completed the trial. All patients received routine
perioperative care. Patients were allocated to one of three treatment
groups: intraoperative cell salvage, intraoperative cell salvage with acute perioperative normovolaemic haemodilution, or no mechanical blood
conservation. There were 84 patients in each group.
Main outcome measures:
Numbers of patients who
received allogeneic blood or coagulation products, and the mean number
of units of blood transfused per patient.
Results:
Of the patients in the
intraoperative cell salvage group, 26 were given a transfusion of
allogeneic blood, compared with 43 in the control group (odds ratio
0.43 (95% confidence interval 0.23 to 0.80)). The mean number of units of allogeneic blood transfused per patient in the intraoperative cell
salvage group was 0.68 units (SD=1.55), compared with 1.07 (1.56)
units in the control group. 32 of the patients in the intraoperative cell salvage group were given any blood product, compared with 47 in
the control group (odds ratio 0.47 (0.25 to 0.89); P=0.019). Combining acute perioperative normovolaemic haemodilution with intraoperative cell salvage conferred no additional benefits.
Conclusions:
An intraoperative cell
salvage device should be used in elective coronary artery bypass
grafting. Pharmacological strategies may achieve further reductions in
blood transfusions. Yet further reductions in blood transfusions could
be achieved if the lower safe limit of haemoglobin concentration in
patients undergoing cardiac surgery were known.
Patients undergoing elective coronary artery bypass surgery often need
a blood transfusion
Intraoperative cell salvage significantly reduces the number of
patients needing an allogeneic blood transfusion
Read all Rapid Responses